1st Quarter - Report

AMERICAN SOCIETY FOR RADIATION ONCOLOGY for AMERICAN SOCIETY FOR RADIATION ONCOLOGY

Firm
Client
Income
—
Expenses
$188,785
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FY2026 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support for NRC Commissioner nominee to have medical background Radiation Oncology reimbursement Policy initiatives designed to increase transparency in the prior authorization process Efforts to educate legislators about unintended consequences associated with rate setting for health care services Preserve current training and experience requirements for radiopharmaceuticals Support current NRC medical event reporting regulations and patient safety protocols without additional requirements for extravasations

LobbyistCovered position, as disclosed
DAVID ADLER —
ZACHARY CONNOR HARRIS —
CYNTHIA TOMLINSON —
COURTNEY WILLIAMS —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Nuclear Regulatory Commission (NRC)

Medicare/Medicaid MMM

Oppose CMS's "efficiency adjustment" Support for structural changes that lead to delivering high quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers Support for reforming the way Medicare pays for radiation oncology services by tying payments to quality and value Support for protecting access to care for Medicare patients Oppose physician fee schedule cuts due to clinical labor price updates Support for H.R. 2120 and S. 1031, a bill to modernize radiation oncology reimbursement - The Radiation Oncology Case Rate Value Based Program Act of 2025 Support for H.R. 879, to fix Medicare Physician Fee Schedule's physician payment reimbursement cuts Support H.R.3514, S.1816, the Improving Seniors' Timely Access to Care Act Support for H.R. 6160, Strengthening Medicare for Patients and Providers Act

LobbyistCovered position, as disclosed
DAVID ADLER —
ZACHARY CONNOR HARRIS —
CYNTHIA TOMLINSON —
COURTNEY WILLIAMS —

Contacted: Office of Management & Budget (OMB); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 6160 (119th), S. 1031 (119th), S. 1816 (119th), H.R. 3514 (119th), H.R. 879 (119th), H.R. 2120 (119th)

Homeland Security HOM

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC)

LobbyistCovered position, as disclosed
DAVID ADLER —
ZACHARY CONNOR HARRIS —
CYNTHIA TOMLINSON —
COURTNEY WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Nuclear Regulatory Commission (NRC)

Budget/Appropriations BUD

Support legislation to increase the budget for the National Institutes of Health, National Cancer Institute and the Centers for Disease Control and Prevention for FY 2026 and FY2027 Support for increased funding for radiation therapy cooperative groups within the National Cancer Institute Support for the National Institutes of Health to recognize radiation oncology as an individual specialty in reporting systems to create more transparency of federal appropriations Support for ARPA-H to support innovative cancer treatments Support for initiatives to increase diversity in clinical trials Support for DOD lung cancer research program funding Support for report language encouraging NIH to support research into functional radiation medicine

LobbyistCovered position, as disclosed
DAVID ADLER —
ZACHARY CONNOR HARRIS —
CYNTHIA TOMLINSON —
COURTNEY WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.